Megan Adediran: Giving Hope to People Living with Bleeding Disorders
Megan Adediran, Executive Director at Hemophilia Foundation of Nigeria, shared a post LinkedIn:
“My journey in advocacy began through the pain of watching my son live with a bleeding disorder and experiencing firsthand the fear, uncertainty, and challenges that come with limited awareness and access to care.
As I walked that journey with him, I began to see that many other individuals and families were also suffering silently due to delayed diagnosis, stigma, misunderstanding, and inadequate support.
Over the years, I have listened to stories of pain, resilience, and survival that strengthened my passion to keep speaking up for those whose voices are often unheard, especially women and girls whose symptoms are frequently dismissed or misunderstood.
Through awareness campaigns, community engagements, partnerships, and storytelling, I have learned that advocacy is not just about raising awareness.
It is about creating change, restoring hope, and ensuring that people feel seen, heard, and supported.
This journey continues to remind me that one voice, when used with purpose, can truly make a difference.”
Other posts featuring Megan Adediran on Hemostasis Today.
-
Sep 11, 2026, 09:51Alfredo Lozada: Pelacarsen Lowers Lp(a), But Does It Lower CV Risk?
-
Sep 11, 2026, 09:35Yasir Khan: Travel Related Blood Clots – What Are the Chances?
-
Sep 11, 2026, 08:02Mud Alvi: Restarting Antithrombotic Therapy After Hemorrhagic Transformation of Ischemic Stroke
-
Sep 11, 2026, 08:01Chaza Alaji: Factor X From Inherited Deficiency to Acquired Deficiency in AL Amyloidosis
-
Sep 11, 2026, 08:01Mariusz Kowalewski: Risk Stratification of Surgical Ablation During Minimally Invasive Mitral Valve Surgery for AFib
-
Sep 11, 2026, 08:00Noor Gajraj: MTHFR Helps Turn Folate, Vitamin B9, Into The Form The Body Uses
-
Sep 11, 2026, 07:59Lisa Lacy: Living With Hereditary Antithrombin Deficiency and the Constant Threat of Clotting
-
Sep 11, 2026, 03:10Chris Oung: Anticoagulation for Atrial Fibrillation with Intermediate Stroke Risk
-
Sep 10, 2026, 21:33J. Meireles-Brandao: Lp(a)HORIZON and the Role of Inflammation in ASCVD